An early and complete reperfusion strategy for acute myocardial infarction using fibrinolysis and subsequent transluminal therapy: The FAST trial

Circulation Journal

Volumn 66, Issue 6, 2002, Pages 576-582

  Nagao, Ken ^a   Hayashi, Nariyuki ^a   Kanmatsuse, Katsuo ^a   Kikuchi, Satoru ^a   Ohuba, Tomiya ^a   Takahashi, Hiroshi ^a  

^a SURUGADAI NIHON UNIVERSITY HOSPITAL   (Japan)

Author keywords

Acute myocardial infarction; Adjuvant percutaneous coronary intervention; Coronary reperfusion; Thrombolytic therapy

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; FIBRINOLYTIC AGENT; HEPARIN; MONTEPLASE; PROUROKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY REPERFUSION; DRUG EFFICACY; DRUG SAFETY; EXPERIENCE; FEMALE; FIBRINOLYSIS; FIBRINOLYTIC THERAPY; HEART MUSCLE REPERFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; RECANALIZATION; RISK BENEFIT ANALYSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0036306832     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.66.576     Document Type: Article

References (54)

1. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction
2. A prospective trial of intravenous streptokinase in acute myocardial infarction (ISAM): Mortality, morbidity and infarct size at 21 days
3. Effect of intravenous APSAC on mortality after acute myocardial infarction: Preliminary report of a placebo-controlled clinical trial
4. Trial of tissue plasminogen activation for mortality reduction in acute myocardial infarction: Anglo-Scandinavian Study of Early Thrombolysis (ASSET)
5. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2
6. Comparison of intravenous urokinase plus heparin versus heparin alone in acute myocardial infarction
7. ISIS-3: A randomised comparison of streptokinase vs. tissue plasminogen activator versus anistreplase and of aspirin plus heparin versus aspirin alone among 41,299 cases of suspected acute myocardial infarction
8. Randomized trial of late thrombolysis in patients with suspected acute myocardial infarction
9. Late Assessment of Thrombolytic Efficacy (LATE) Study with alteplase 6-24h after onset of acute myocardial infarction
10. Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction
11. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
12. Guidelines for the early management of patients with acute myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee to Develop Guideline for the Early Management of Patients With Acute Myocardial Infarction)
13. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more 1000 patients
14. ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)
15. 1999 Update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)
16. Thrombolytic therapy for acute myocardial infarction: A review
17. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction
18. Angiographic study of mutant tissue-type plasminogen activator versus urokinase for acute myocardial infarction
19. The complications of mutant t-PA
20. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction
21. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction
22. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction
23. Limitation of infarct size and preservation of left ventricular function after primary coronary angioplasty compared with intravenous streptokinase in acute myocardial infarction
24. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction
25. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: The GUSTO V randomised trial
26. Abciximab facilitates the rate and extent of thrombolysis: Results of the thrombolysis in myocardial infarction (TIMI) 14 trial
27. Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction
28. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: The PACT trial: Plasminogen-activator Angioplasty Compatibility Trial
29. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase
30. Usefulness of SUNK rescue catheter after coronary occulusion during percutaneous transluminal coronary angioplasty
31. Clinical measurement of myocardial infarct size: Modification of a method for the estimation of total creatine phosphokinase release after myocardial infarction
32. New method-intracoronary thrombolysis on acute myocardial infarction
33. Current Japanese strategy to AMI
34. Admission status of patients with acute myocardial infarction in Tokyo: A survey of all hospitals in 1994
35. A current role of coronary thrombolysis and PTCA in patients registry in the Tokyo CCU network
36. Effect of coronary thrombolytic therapy on the degree of collateral development
37. Strategies after coronary thrombolysis in patients with acute myocardial infarction
38. ACC/AHA guidelines for percutaneous coronary intervention (Revision of the 1993 PTCA guidelines): Executive summary
39. The effects and problems of combination reperfusion therapy (FAST therapy: Fibrinolysis and subsequent transluminal therapy) in patients with acute myocardial infarction
40. A prospective, randomized, double-blind multicenter trial of a single bolus injection of the novel modified t-PA E6010 in the treatment of acute myocardial infarction: Comparison with native t-PA: E6010 Study Group
41. A comparison of reteplase with alteplase for acute myocardial infarction
42. Randomized, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): Trial to investigate equivalence
43. Single bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: The assent-2 double-blind randomized trial
44. Results from late-breaking clinical trial sessions at ACCIS '99 and ACC '99
45. Rescue angioplasty after failed thrombolysis: Technical and clinical outcomes in a large thrombolysis trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries
46. Effects of coronary artery reperfusion on myocardial infarct size calculated from creatine kinase
47. Intracoronary thrombolysis in acute myocardial infarction: An attempt to quantitate its effect by comparison of enzymatic estimate of myocardial necrosis with left ventricular ejection fraction
48. Troponin T: A diagnostic marker for myocardial infarction and minor cardiac cell damage
49. Estimation of infarct size using serum troponin T concentration in patients with acute myocardial infarction
50. Cardiac troponin T levels for risk stratification in acute myocardial ischemia
51. Relationship among the troponin T level, the myosin light chain I and the left ventricular function in patients with reperfused AMI
52. Guideline 2000 for cardiopulmonary resuscitation and emergency cardiovascular care
53. Effects of combined emergency percutaneous cardiopulmonary support and reperfusion treatment in patients with refractory ventricular fibrillation complicating acute myocardial infarction
54. Cardiopulmonary cerebral resuscitation using emergency cardiopulmonary bypass, coronary reperfusion therapy and mild hypothermia in patients with cardiac arrest outside the hospital